Szépkúti, Sándor http://orcid.org/0000-0002-0197-7687
Bandur, Szilvia http://orcid.org/0000-0001-8808-5595
Kovács, Gábor http://orcid.org/0000-0003-0713-6894
Ferenci, Tamás http://orcid.org/0000-0001-6791-3080
Svébis, Márk M. http://orcid.org/0000-0002-6624-9621
Turbucz, Piroska
Tabák, Ádám G. http://orcid.org/0000-0002-6234-3936
Funding for this research was provided by:
Semmelweis University
Article History
Received: 30 May 2022
Accepted: 26 August 2022
First Online: 14 September 2022
Declarations
:
: All study related procedures have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Local ethical approval was obtained from the Ethics Committee of Pest County Flór Ferenc Hospital, Kistarcsa, Hungary; Registration number: 119/17/2017. The need for informed consent was waived in accordance with Hungarian laws by the Ethics Committee of Pest County Flór Ferenc Hospital, Kistarcsa, Hungary.
: Not applicable.
: SSz has received consultancy and advisory board fees from Lilly Hungária, Novo Nordisk, and Sanofi; and speaker fees from Lilly Hungária, Novo Nordisk, and Sanofi. SzB has received consultancy and advisory board fees from Sanofi; and speaker fees from MSD, Novo Nordisk, and Sanofi. GK has received speaker fees from IPSEN, and Sanofi. TF has no potential sources of conflict of interest to disclose. MMS has received speaker fees from Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Medtronic, 77 Elektronika, Krka and Egis Pharmaceuticals. PT has received consultancy, advisory board and speaker fees from Novo Nordisk and Sanofi. AGT has received consultancy and advisory board fees from 77 Elektronika, Lilly Hungária, and Sanofi; and speaker fees from AstraZeneca, Berlin-Chemie, Eli Lilly, Novo Nordisk, and Sanofi. AGT was supported by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund (2021 Thematic Excellence Programme funding scheme, TKP2021-NKTA-47).